Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Weydt

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Neuroreport|April 7, 2005
Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosisPatrick Weydt, Thomas Möller
Practical Neurology|January 2, 2026
Hereditary transthyretin amyloidosis with hand weakness and bulbar involvementSarah Bernsen, Patrick Weydt
Handbook of Clinical Neurology|November 16, 2019
The psychopharmacology of Huntington diseaseÅsa Petersén, Patrick Weydt
Current Drug Targets|September 16, 2010
The role of PGC-1α in the pathogenesis of neurodegenerative disordersKrisztina Róna-Vörös, Patrick Weydt
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Cannabis: old medicine with new promise for neurological disordersGregory T Carter, Patrick Weydt
Expert Opinion on Therapeutic Targets|July 20, 2006
Targeting protein aggregation in neurodegeneration--lessons from polyglutamine disordersPatrick Weydt, Albert R La Spada
Handbook of Clinical Neurology|November 22, 2018
Thermoregulation in amyotrophic lateral sclerosisLuc Dupuis, Åsa Petersen, Patrick Weydt
Handbook of Clinical Neurology|November 22, 2018
Thermoregulatory disorders in Huntington diseasePatrick Weydt, Luc Dupuis, Åsa Petersen
Brain and Behavior|June 4, 2026
Attentional Function in Patients With Amyotrophic Lateral Sclerosis is Moderated by Age and EducationMaher Zoubi, Patrick Weydt, Xenia Kobeleva
Expert Opinion on Pharmacotherapy|April 23, 2004
Current pharmacological management of amyotrophic [corrected] lateral sclerosis and a role for rational polypharmacyMichael D Weiss, Patrick Weydt, Gregory T Carter
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Neuroreport|April 7, 2005
Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosisPatrick Weydt, Thomas Möller
Practical Neurology|January 2, 2026
Hereditary transthyretin amyloidosis with hand weakness and bulbar involvementSarah Bernsen, Patrick Weydt
Handbook of Clinical Neurology|November 16, 2019
The psychopharmacology of Huntington diseaseÅsa Petersén, Patrick Weydt
Current Drug Targets|September 16, 2010
The role of PGC-1α in the pathogenesis of neurodegenerative disordersKrisztina Róna-Vörös, Patrick Weydt
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Cannabis: old medicine with new promise for neurological disordersGregory T Carter, Patrick Weydt
Expert Opinion on Therapeutic Targets|July 20, 2006
Targeting protein aggregation in neurodegeneration--lessons from polyglutamine disordersPatrick Weydt, Albert R La Spada
Handbook of Clinical Neurology|November 22, 2018
Thermoregulation in amyotrophic lateral sclerosisLuc Dupuis, Åsa Petersen, Patrick Weydt
Handbook of Clinical Neurology|November 22, 2018
Thermoregulatory disorders in Huntington diseasePatrick Weydt, Luc Dupuis, Åsa Petersen
Brain and Behavior|June 4, 2026
Attentional Function in Patients With Amyotrophic Lateral Sclerosis is Moderated by Age and EducationMaher Zoubi, Patrick Weydt, Xenia Kobeleva
Expert Opinion on Pharmacotherapy|April 23, 2004
Current pharmacological management of amyotrophic [corrected] lateral sclerosis and a role for rational polypharmacyMichael D Weiss, Patrick Weydt, Gregory T Carter
Pageof 11